Gene · 4973
Papers4,129
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,129
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Organotypic 3D Cell-Architecture Impacts the Expression Pattern of miRNAs-mRNAs Network in Breast Cancer SKBR3 Cells. | Noncoding RNA | 2023 | 37987362 | PubTator, text mining | PubMed |
| Exploring the mechanism of Erchen decoction in the treatment of atherosclerosis based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2023 | 37986321 | PubTator, text mining | PubMed |
| Comparative efficacy of Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta- analysis. | Chin Med | 2023 | 37986011 | PubTator, text mining | PubMed |
| Relationship of Soluble Lectin-Like Low-Density Lipoprotein Receptor-1 (sLOX-1) With Inflammation and Coronary Plaque Progression in Psoriasis. | J Am Heart Assoc | 2023 | 37982276 | PubTator, text mining | PubMed |
| Higher HDL cholesterol levels are associated with increased markers of interstitial myocardial fibrosis in the MultiEthnic Study of Atherosclerosis (MESA). | Sci Rep | 2023 | 37978334 | PubTator, text mining | PubMed |
| Endothelial cell dysfunction in cardiac disease: driver or consequence? | Front Cell Dev Biol | 2023 | 37965580 | PubTator, text mining | PubMed |
| The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target. | Int J Mol Sci | 2023 | 37958500 | PubTator, text mining | PubMed |
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients. | Cancers (Basel) | 2023 | 37958458 | PubTator, text mining | PubMed |
| Dyslipidemia in rheumatoid arthritis: the possible mechanisms. | Front Immunol | 2023 | 37954591 | PubTator, text mining | PubMed |
| A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder. | Drugs R D | 2023 | 37938531 | PubTator, text mining | PubMed |
| Construction and validation of a novel angiogenesis pattern to predict prognosis and immunotherapy efficacy in colorectal cancer. | Aging (Albany NY) | 2023 | 37938164 | PubTator, text mining | PubMed |
| Multi-target mechanism of Naoshuantong capsule for treatment of Ischemic stroke based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2023 | 37933045 | PubTator, text mining | PubMed |
| Arachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts. | JHEP Rep | 2023 | 37916155 | PubTator, text mining | PubMed |
| Leukocyte-endothelial interaction in CKD. | Clin Kidney J | 2023 | 37915921 | PubTator, text mining | PubMed |
| Wall Teichoic Acid Mediates Staphylococcus aureus Binding to Endothelial Cells via the Scavenger Receptor LOX-1. | ACS Infect Dis | 2023 | 37910786 | PubTator, text mining | PubMed |
| Identification of ferroptosis-related genes in type 2 diabetes mellitus based on machine learning. | Immun Inflamm Dis | 2023 | 37904700 | PubTator, text mining | PubMed |
| Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer. | Front Immunol | 2023 | 37901214 | PubTator, text mining | PubMed |
| Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome. | Life (Basel) | 2023 | 37895374 | PubTator, text mining | PubMed |
| Roles of Oxidative Injury and Nitric Oxide System Derangements in Kawasaki Disease Pathogenesis: A Systematic Review. | Int J Mol Sci | 2023 | 37895129 | PubTator, text mining | PubMed |
| Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions. | Int J Mol Sci | 2023 | 37894988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/papers?page=18